We found that the prevalence of lifetime use was 2.5x higher among people with eating disorders compared to the general adult population. About 1 in 10 people with an eating disorder reported misuse of a GLP-1 drug (e.g., tampering with syringes, accelerating doses, sharing with others). #EDAW